UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005850
Receipt number R000006912
Scientific Title Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer
Date of disclosure of the study information 2011/07/01
Last modified on 2019/03/18 19:22:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer

Acronym

4'-[methyl-11C]thiotymidine(4DST)PET for cancer diagnosis

Scientific Title

Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer

Scientific Title:Acronym

4'-[methyl-11C]thiotymidine(4DST)PET for cancer diagnosis

Region

Japan


Condition

Condition

Lung cancer
Multiple myeloma
Esophageal cancer
Head and neck caner

Classification by specialty

Gastroenterology Cardiology Pneumology
Hematology and clinical oncology Gastrointestinal surgery Chest surgery
Oto-rhino-laryngology Radiology Cardiovascular surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the utility of 4DST-PET for diagnosis and therapy evaluation of cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

As a surrogate marker of tumor proliferation and of therapeutic response, 4DST-PET could be superior than FDG-PET.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

4DSTPET and FDGPET in a same patient will be compared to the pathology or to the clinical golden standards.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patient who is pathologically diagnosed as malignancy.
2.Age: >20 years.
3. Capability to have PET scan.
4. Completed the written informed consent

Key exclusion criteria

1. Unable to have signed informed consent.
2.Patient with severe underlying disease having risk of liver dysfunction, renal dysfunction and any metabolic damage.
3. Just after surgery and/or trauma
4. Uncontrollable diabetics
5. Those who are determined as not appropriate for the study by physician in chief.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryogo Minamimoto

Organization

National Center for Global Health and Medicine

Division name

Department of Radiology, Division of Nuclear Medicine

Zip code


Address

1-21-1, Toyama, Shinjyuku-ku, Tokyo

TEL

03-3202-7181

Email

rminamimoto@hosp.ncgm.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryogo Minamimoto

Organization

National Center for Global Health and Medicine

Division name

Department of Radiology, Division of Nuclear Medicine

Zip code


Address

1-21-1, Toyama, Shinjyuku-ku, Tokyo

TEL

03-3202-7181

Homepage URL


Email

rikensa@lily.ocn.ne.jp


Sponsor or person

Institute

National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

National Center for Global Health and Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Tokyo Metropolitan Institute for Gerontology

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立国際医療研究センター病院(東京都)


Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

We compared the maximum standardized uptake value (SUVmax) of lung tumors on both 11C-4DST and 18F-FDG PET/CT with the Ki-67 index of cellular proliferation and with CD31-positive vessels as a marker of angiogenesis in surgical pathology. The correlation coefficient between SUVmax and Ki-67 index was higher with 11C-4DST (r = 0.82) than with 18F-FDG (r = 0.71). That with CD31 was low for both tracers. 11C-4DST PET/CT may allow noninvasive imaging of DNA synthesis in NSCLC.
Minamimoto R, st al. J Nucl Med 2012;53:199-206.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 06 Month 01 Day

Date of IRB

2010 Year 06 Month 25 Day

Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

FDG uptake by tumor tissue, 4DST uptake by tumor tissue, MIB-1 index by immuno-staining of Ki-67 of resected tumor tissue, histopathological type, these informations will be compared.


Management information

Registered date

2011 Year 06 Month 26 Day

Last modified on

2019 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006912


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name